Abstract

Following a 90-min coronary occlusion and 2 h reperfusion in 11 dogs, total tissue and subcellular distributions of [ 3H]digoxin in non-ischemic and various ischemictissues were measured. In the non-ischemic tissue, [ 3H]digoxin in the crude homogenate, sediments obtained from 1000 × g, 10 000 × g and 100 000 × g centrifugations, and final supernatant fraction were 0.70 ± 0.05, 0.64 ± 0.04, 3.87 ± 0.34 and 0.19 ± 0.02 ng/mg protein, respectively. As in studies with total tissue [ 3H]digoxin uptake, a reciprocal correlation was observed in reduction of digoxin binding in the crude homogenates and the 1 000 × g sediments with increasing severity of ischemic injury estimated from the loss of nitro-blue-tetrazolium (NBT) stain. A 20% and 80% loss of NBT stain was associated with a 13.3% and 63.5% decrease in digoxin binding, respectively. In contrast, digoxin binding in the 10 000 × g sediments increased progressively with the severity of ischemia. No significant change was observed in the final supernatant fraction. Digoxin binding in the 100 000 × g sediments, which generally represent specific binding and which are associated with the pharmacologic effect, was not altered in tissues with a loss of NBT stain up to 50%. In fact, a loss of 80% NBT was associated with only a 33.9% decrease in digoxin binding. Thus, it appears that measurement of total tissue digoxin uptake does not provide an accurate measure of the effects of acute ischemia on specific digoxin binding. The ability of the peri- and moderately ischemic tissues (with less than 50% loss of NBT stain) to specifically bind digitalis was not altered after temporary myocardial ischemia.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call